Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.64763 | 73 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.57927 | 72 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.60286 | 72 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.43365 | 70 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.47308 | 71 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.52755 | 72 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.58822 | 72 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.55627 | 72 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.54604 | 72 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.67451 | 73 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.5643 | 72 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.55109 | 72 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.61544 | 72 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.56703 | 72 |